Medipharm Historical Financial Ratios
| LABS Stock | CAD 0.07 0.01 6.25% |
Medipharm Labs is lately reporting on over 96 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 70.75 will help investors to properly organize and evaluate Medipharm Labs Corp financial condition quickly.
Medipharm |
About Medipharm Financial Ratios Analysis
Medipharm Labs CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Medipharm Labs investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Medipharm financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Medipharm Labs history.
Medipharm Labs Financial Ratios Chart
Add Fundamental
Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from Medipharm Labs' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Medipharm Labs Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medipharm Labs Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Medipharm Labs' Current Ratio is very stable compared to the past year. As of the 4th of March 2025, Tangible Book Value Per Share is likely to grow to 0.24, while Price To Sales Ratio is likely to drop 0.78.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 214.62 | 64.76 | 74.47 | 70.75 | PTB Ratio | 0.35 | 0.45 | 0.51 | 0.49 |
Medipharm Labs fundamentals Correlations
Click cells to compare fundamentals
Medipharm Labs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medipharm Labs fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 2.04 | 2.13 | 0.88 | 0.71 | 0.82 | 0.78 | |
| Ptb Ratio | 0.94 | 0.56 | 0.35 | 0.45 | 0.51 | 0.49 | |
| Days Sales Outstanding | 280.99 | 284.42 | 214.62 | 64.76 | 74.47 | 70.75 | |
| Book Value Per Share | 0.57 | 0.33 | 0.2 | 0.15 | 0.13 | 0.24 | |
| Operating Cash Flow Per Share | (0.27) | (0.0529) | (0.058) | (0.034) | (0.0391) | (0.041) | |
| Stock Based Compensation To Revenue | 0.12 | 0.0744 | 0.11 | 0.13 | 0.0613 | 0.0705 | |
| Capex To Depreciation | 0.69 | 0.14 | 0.3 | 0.19 | 0.22 | 0.2 | |
| Pb Ratio | 0.94 | 0.56 | 0.35 | 0.45 | 0.51 | 0.49 | |
| Ev To Sales | 2.0 | 0.57 | (0.19) | 0.24 | 0.28 | 0.26 | |
| Free Cash Flow Per Share | (0.33) | (0.056) | (0.0612) | (0.0353) | (0.0317) | (0.0333) | |
| Roic | (0.66) | (0.59) | (0.52) | (0.32) | (0.29) | (0.31) | |
| Inventory Turnover | 3.61 | 3.37 | 3.09 | 2.75 | 2.47 | 2.02 | |
| Net Income Per Share | (0.48) | (0.22) | (0.11) | (0.036) | (0.0414) | (0.0435) | |
| Days Of Inventory On Hand | 101.02 | 108.4 | 118.11 | 132.8 | 152.72 | 225.29 | |
| Payables Turnover | 14.42 | 12.36 | 6.79 | 12.77 | 11.5 | 6.89 | |
| Sales General And Administrative To Revenue | 0.68 | 0.85 | 0.83 | 0.65 | 0.59 | 0.5 | |
| Research And Ddevelopement To Revenue | 0.0618 | 0.0624 | 0.0453 | 0.006321 | 0.005689 | 0.005405 | |
| Capex To Revenue | 0.21 | 0.0361 | 0.039 | 0.0142 | 0.0164 | 0.0156 | |
| Cash Per Share | 0.16 | 0.14 | 0.0899 | 0.0502 | 0.0578 | 0.0549 | |
| Pocfratio | (1.94) | (3.5) | (1.21) | (1.91) | (1.72) | (1.81) | |
| Interest Coverage | (9.22) | (4.66) | (952.68) | (50.01) | (57.51) | (60.38) | |
| Capex To Operating Cash Flow | (0.2) | (0.0593) | (0.0537) | (0.0382) | (0.0439) | (0.0417) | |
| Pfcf Ratio | (1.62) | (3.3) | (1.14) | (1.84) | (1.66) | (1.74) | |
| Days Payables Outstanding | 25.32 | 29.54 | 53.75 | 28.58 | 32.86 | 31.22 | |
| Income Quality | 0.56 | 0.24 | 0.54 | 0.94 | 0.85 | 0.89 | |
| Roe | (0.86) | (0.66) | (0.54) | (0.25) | (0.22) | (0.23) | |
| Ev To Operating Cash Flow | (1.91) | (0.93) | 0.26 | (0.64) | (0.58) | (0.61) | |
| Pe Ratio | (1.09) | (0.84) | (0.65) | (1.81) | (1.62) | (1.54) | |
| Return On Tangible Assets | 0.006699 | (0.57) | (0.59) | (0.46) | (0.21) | (0.19) | |
| Ev To Free Cash Flow | (1.59) | (0.88) | 0.24 | (0.62) | (0.56) | (0.59) | |
| Earnings Yield | (0.91) | (1.19) | (1.55) | (0.55) | (0.64) | (0.67) | |
| Net Debt To E B I T D A | 0.0272 | 0.88 | 0.87 | 1.5 | 1.35 | 1.41 | |
| Current Ratio | 3.36 | 7.38 | 5.01 | 3.37 | 3.04 | 3.08 | |
| Tangible Book Value Per Share | 0.56 | 0.33 | 0.2 | 0.14 | 0.13 | 0.24 | |
| Receivables Turnover | 1.3 | 1.28 | 1.7 | 5.64 | 5.07 | 5.33 | |
| Graham Number | 2.48 | 1.28 | 0.7 | 0.34 | 0.31 | 0.29 | |
| Shareholders Equity Per Share | 0.57 | 0.33 | 0.2 | 0.15 | 0.13 | 0.12 | |
| Debt To Equity | 0.24 | 0.002598 | 0.0113 | 0.0433 | 0.0498 | 0.0473 |
Pair Trading with Medipharm Labs
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medipharm Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will appreciate offsetting losses from the drop in the long position's value.Moving against Medipharm Stock
The ability to find closely correlated positions to Medipharm Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medipharm Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medipharm Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medipharm Labs Corp to buy it.
The correlation of Medipharm Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medipharm Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medipharm Labs Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medipharm Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Medipharm Stock
Medipharm Labs CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Medipharm Labs investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Medipharm financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Medipharm Labs history.